Low-dose naltrexone's utility for non-cancer centralized pain conditions: a scoping review.

Authors:
Rupp A; Young E; Chadwick AL.

Journal:
Pain Med

Publication Year: 2023

DOI:
10.1093/pm/pnad074

PMCID:
PMC10628981

PMID:
37302106

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pain Med

Abbreviation: Pain Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Athrodesis of the lateral atlanto-axial joint for the relief of neck pain and cervicogenic headache.
Ferch RD; Zhang T; Bogduk N. (2024) - Transparency Score: 3/6
Low back pain-related healthcare utilization following intraosseous basivertebral nerve radiofreque…
McCormick ZL; Curtis T; Cooper A and 2 more (2024) - Transparency Score: 4/6
Patient-related barriers and enablers to the implementation of high-value physiotherapy for chronic…
Dickson C; de Zoete RMJ; Berryman C and 3 more (2024) - Transparency Score: 5/6
Suicidal ideation in female individuals with fibromyalgia and comorbid obesity: prevalence and asso…
Varallo G; Scarpina F; Arnison T and 12 more (2024) - Transparency Score: 3/6
Age as a moderator in the interplay among locus of control, coping, and quality of life of people w…
Kłosowska J; Farley D; Brączyk J and 2 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest A.L.C. receives research funding from the National Institute of General Medical Sciences of the National Institutes of Health under award number K23GM123320. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. A.L.C. is a consultant for Swing Therapeutics and Scilex Pharmaceuticals."

Evidence found in paper:

"Funding None declared."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025